Faeth Therapeutics, Inc. - 8-K Filing

Faeth Therapeutics reports encouraging Phase 2 topline clinical data for PIKTOR in advanced endometrial cancer. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $SNSE

Read the full article at SEC EDGAR

More Regulatory news